BJMO - volume 13, issue 3, may 2019
M. Schapira MD
Concerning the review published in BJMO issue 2, March 2019:
The role of direct oral anticoagulants in the management of cancer-associated thrombosis
A. Awada, J-F. Baurain, P. Clement, P. Hainaut, S. Holbrechts, K. Jochmans, V. Mathieux, J. Mebis, M. Strijbos, C. Vulsteke, T. Vanassche, P. Verhamme (BELG J MED ONCOL 2019;13(2):46-53)
(BELG J MED ONCOL 2019;13(3):83)
Read moreBJMO - volume 10, issue 7, november 2016
J-M. Hougardy , S. Motte
(BELG J MED ONCOL 2016;10(7):240–242)
Read moreBJMO - volume 7, issue 3, july 2013
A. Hugo MD
Concerning the previously published letter to the editor:
The COMPARZ study presented at ESMO 2012: how pliable is non-inferiority?
L. Van den Hove, Belg J Med Oncol 2013;7(1):3–7
(BELG J MED ONCOL 2013;7(3):72–73)
Read moreBJMO - volume 7, issue 1, february 2013
J. De Grève MD, PhD
(BELG J MED ONCOL 2013;7:3-7)
Read moreBJMO - volume 7, issue 1, february 2013
W.A.A. Tjalma MD, PhD
Concerning the previously published article:
Smeets A, Carly B, Cocquyt V, et al. The changing role of axillary dissection in the treatment of breast cancer. Belg J Med Oncol 2012;6:78–95
(BELG J MED ONCOL 2013;7:8–9)
Read moreBJMO - volume 6, issue 5, october 2012
C. Colpaert MD, PhD, K. Lambein MD, PhD, on behalf of the Belgian Working Group for Breast Pathology
(BELG J MED ONCOL 2012;6:183-184)
Read moreBJMO - volume 6, issue 4, september 2012
B. Lelie MD
Top
